News
Have you managed a patient on an unboosted INSTI with an enzyme inducer?
We’re collecting real-world clinical cases to better understand drug interactions between unboosted integrase inhibitors (such as dolutegravir or bictegravir) and enzyme inducers (including rifampicin or carbamazepine).
Your experience could contribute to safer prescribing and help shape clinical practice.